{"nctId":"NCT00928434","briefTitle":"A Study of Degarelix in Patients With Prostate Cancer","startDateStruct":{"date":"2009-05"},"conditions":["Prostate Cancer"],"count":409,"armGroups":[{"label":"DI (Degarelix Intermittent)","type":"EXPERIMENTAL","interventionNames":["Drug: Degarelix"]},{"label":"DC (Degarelix Continuous)","type":"EXPERIMENTAL","interventionNames":["Drug: Degarelix"]},{"label":"LC (Leuprolide Continuous)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Leuprolide"]}],"interventions":[{"name":"Degarelix","otherNames":[]},{"name":"Degarelix","otherNames":[]},{"name":"Leuprolide","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 18 years or older.\n* Raising PSA after prior treatment failure of localized prostate cancer.\n* Has a histological confirmed non-metastatic cancer of the prostate (Gleason graded) based on the most current biopsy.\n* Has a screening testosterone within normal range (≥1.5 ng/mL).\n* Has Eastern Cooperative Oncology Group score of ≤2.\n* Bone scan or CT scan report documenting no evidence of metastasis to the bone or internal organs.\n* Life expectancy of at least 15 months.\n\nExclusion Criteria:\n\n* Taken hormone therapy in the last 6 months prior to entering this study.\n* Being treated with 5-alpha reductase inhibitor at time of enrolment and remained on a stable dose throughout the trial.\n* Has a history of severe uncontrolled asthma, anaphylactic reactions, or severe urticaria and/or angioedema.\n* Has hypersensitivity towards any component of the study drug.\n* Has a previous history or presence of another malignancy other than prostate cancer or treated squamous/basal cell carcinoma of the skin within the last five years.\n* Has abnormal laboratory results which in the judgement of the Investigator would affect the patient's health or the outcome of the trial.\n* Has a clinically significant medical condition (other than prostate cancer) including but not limited to; renal, haematological, gastrointestinal, endocrine, cardiac, neurological or psychiatric disease and alcohol or drug abuse or any other condition which may affect the patient's health or the outcome of the trial as judged by the Investigator.\n* Has an intellectual incapacity or language barriers precluding adequate understanding or co-operation.\n* Has received an investigational drug within the last 28 days before the Screening visit or longer if considered to possibly influence the outcome of the current trial.\n* Has received ketoconazole or diflucan in the last 28 days preceding the Screening Visit.\n* Has previously participated in any Degarelix trial.\n* Is part of an ongoing trial.","healthyVolunteers":false,"sex":"MALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage of Patients With Serum PSA Levels ≤4.0 ng/mL","description":"Percentage of patients with serum PSA levels ≤4.0 ng/mL at 14 month was presented.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"98.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline in Serum PSA Levels","description":"Absolute change from Baseline in serum PSA levels during the study period was measured.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA"},{"groupId":"OG001","value":"-0.91","spread":"NA"},{"groupId":"OG002","value":"NA","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.39","spread":"10.2"},{"groupId":"OG001","value":"-14.3","spread":"34.8"},{"groupId":"OG002","value":"-6.38","spread":"13.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.94","spread":"10.8"},{"groupId":"OG001","value":"-14.8","spread":"34.9"},{"groupId":"OG002","value":"-8.12","spread":"15.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.07","spread":"10.9"},{"groupId":"OG001","value":"-15","spread":"35"},{"groupId":"OG002","value":"-8.44","spread":"15.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.16","spread":"11"},{"groupId":"OG001","value":"-15.1","spread":"35.2"},{"groupId":"OG002","value":"-8.51","spread":"15.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.19","spread":"11"},{"groupId":"OG001","value":"-15.1","spread":"35.2"},{"groupId":"OG002","value":"-8.59","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.21","spread":"10.9"},{"groupId":"OG001","value":"-15.1","spread":"35.2"},{"groupId":"OG002","value":"-8.64","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.24","spread":"11"},{"groupId":"OG001","value":"-15.1","spread":"35.2"},{"groupId":"OG002","value":"-8.64","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.25","spread":"11"},{"groupId":"OG001","value":"-15","spread":"34.7"},{"groupId":"OG002","value":"-8.64","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.18","spread":"11"},{"groupId":"OG001","value":"-15","spread":"34.7"},{"groupId":"OG002","value":"-8.64","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.07","spread":"10.9"},{"groupId":"OG001","value":"-14.9","spread":"34.3"},{"groupId":"OG002","value":"-8.63","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.96","spread":"10.9"},{"groupId":"OG001","value":"-14.9","spread":"33.9"},{"groupId":"OG002","value":"-8.64","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.81","spread":"11"},{"groupId":"OG001","value":"-14.8","spread":"33.9"},{"groupId":"OG002","value":"-8.64","spread":"15.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.79","spread":"11"},{"groupId":"OG001","value":"-14.8","spread":"33.9"},{"groupId":"OG002","value":"-8.59","spread":"16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.74","spread":"11"},{"groupId":"OG001","value":"-14.8","spread":"33.9"},{"groupId":"OG002","value":"-8.6","spread":"15.9"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Serum PSA Levels","description":"Percent change from Baseline in serum PSA levels during the study period was measured.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA"},{"groupId":"OG001","value":"-39.6","spread":"NA"},{"groupId":"OG002","value":"NA","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-80.8","spread":"24.4"},{"groupId":"OG001","value":"-84.5","spread":"11.8"},{"groupId":"OG002","value":"-62.8","spread":"31.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-90.4","spread":"12.2"},{"groupId":"OG001","value":"-92.4","spread":"8.23"},{"groupId":"OG002","value":"-87.3","spread":"12.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-92.8","spread":"9.9"},{"groupId":"OG001","value":"-94.5","spread":"7.37"},{"groupId":"OG002","value":"-92.3","spread":"7.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-94.1","spread":"8.45"},{"groupId":"OG001","value":"-95.5","spread":"7.05"},{"groupId":"OG002","value":"-93.4","spread":"9.39"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-94.2","spread":"9.31"},{"groupId":"OG001","value":"-95.7","spread":"7.8"},{"groupId":"OG002","value":"-94.5","spread":"7.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-94.8","spread":"8.34"},{"groupId":"OG001","value":"-95.8","spread":"8.64"},{"groupId":"OG002","value":"-95.3","spread":"7.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-95.4","spread":"7.13"},{"groupId":"OG001","value":"-95.4","spread":"10.8"},{"groupId":"OG002","value":"-95.5","spread":"7.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-95.7","spread":"6.97"},{"groupId":"OG001","value":"-95.5","spread":"10.3"},{"groupId":"OG002","value":"-95.2","spread":"12.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-93.6","spread":"11.5"},{"groupId":"OG001","value":"-95.6","spread":"10.6"},{"groupId":"OG002","value":"-94.3","spread":"23.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-91.9","spread":"13.4"},{"groupId":"OG001","value":"-95.7","spread":"9.46"},{"groupId":"OG002","value":"-93.1","spread":"24.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-88","spread":"22.7"},{"groupId":"OG001","value":"-95.1","spread":"11.9"},{"groupId":"OG002","value":"-94.4","spread":"23.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-84.2","spread":"24.9"},{"groupId":"OG001","value":"-95.1","spread":"10.6"},{"groupId":"OG002","value":"-94.5","spread":"23.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-82.8","spread":"24.9"},{"groupId":"OG001","value":"-95.1","spread":"10.4"},{"groupId":"OG002","value":"-93.1","spread":"25.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-80.8","spread":"26.4"},{"groupId":"OG001","value":"-94.4","spread":"12.9"},{"groupId":"OG002","value":"-93.7","spread":"25.8"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life as Assessed by the Functional Assessment of Cancer Therapy-Prostate (FACT-P) : Physical Well-being","description":"The FACT-P is a multidimensional, self-report quality of life (QoL) instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being, which is further supplemented by 12 site specific items to assess for prostate related symptoms. Each question is rated on a scale from 0 to 4, and then combined to produce sub-scale scores for each domain, as well as a global QoL score.\n\nPhysical well-being consist of 7 items and scored on a scale of 0-4 (0=Not at all; 1=A little bit; 2=Somewhat; 3=Quite a bit; 4=Very much). Total score for the physical well-being sub scale ranges from 0 to 28. Higher scores represent better QoL.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.47","spread":null},{"groupId":"OG001","value":"-1.63","spread":null},{"groupId":"OG002","value":"-1.41","spread":null},{"groupId":"OG003","value":"-1.46","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.41","spread":null},{"groupId":"OG001","value":"-1.48","spread":null},{"groupId":"OG002","value":"-1.67","spread":null},{"groupId":"OG003","value":"-1.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.96","spread":null},{"groupId":"OG001","value":"-1.92","spread":null},{"groupId":"OG002","value":"-1.74","spread":null},{"groupId":"OG003","value":"-1.78","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.24","spread":null},{"groupId":"OG001","value":"-1.85","spread":null},{"groupId":"OG002","value":"-1.77","spread":null},{"groupId":"OG003","value":"-1.79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.05","spread":null},{"groupId":"OG001","value":"-2.08","spread":null},{"groupId":"OG002","value":"-1.68","spread":null},{"groupId":"OG003","value":"-1.76","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.00","spread":null},{"groupId":"OG001","value":"-1.77","spread":null},{"groupId":"OG002","value":"-1.53","spread":null},{"groupId":"OG003","value":"-1.58","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.91","spread":null},{"groupId":"OG001","value":"-1.62","spread":null},{"groupId":"OG002","value":"-1.32","spread":null},{"groupId":"OG003","value":"-1.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.00","spread":null},{"groupId":"OG001","value":"-2.10","spread":null},{"groupId":"OG002","value":"-1.40","spread":null},{"groupId":"OG003","value":"-1.55","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.04","spread":null},{"groupId":"OG001","value":"-1.90","spread":null},{"groupId":"OG002","value":"-1.45","spread":null},{"groupId":"OG003","value":"-1.55","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life as Assessed by the FACT-P : Emotional Well-being","description":"The FACT-P is a multidimensional, self-report quality of life (QoL) instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being, which is further supplemented by 12 site specific items to assess for prostate related symptoms. Each question is rated on a scale from 0 to 4, and then combined to produce sub-scale scores for each domain, as well as a global QoL score.\n\nEmotional well-being consist of 6 items and scored on a scale of 0-4 (0=Not at all; 1=A little bit; 2=Somewhat; 3=Quite a bit; 4=Very much). Total score for the emotional well-being sub scale ranges from 0 to 24. Higher scores represent better QoL.Higher scores represent better QoL.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.69","spread":null},{"groupId":"OG001","value":"1.31","spread":null},{"groupId":"OG002","value":"0.76","spread":null},{"groupId":"OG003","value":"0.88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.67","spread":null},{"groupId":"OG001","value":"0.57","spread":null},{"groupId":"OG002","value":"0.90","spread":null},{"groupId":"OG003","value":"0.83","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.65","spread":null},{"groupId":"OG001","value":"0.95","spread":null},{"groupId":"OG002","value":"1.11","spread":null},{"groupId":"OG003","value":"1.08","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.75","spread":null},{"groupId":"OG001","value":"1.11","spread":null},{"groupId":"OG002","value":"1.16","spread":null},{"groupId":"OG003","value":"1.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.09","spread":null},{"groupId":"OG001","value":"0.00","spread":null},{"groupId":"OG002","value":"0.98","spread":null},{"groupId":"OG003","value":"0.77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.82","spread":null},{"groupId":"OG001","value":"0.94","spread":null},{"groupId":"OG002","value":"1.05","spread":null},{"groupId":"OG003","value":"1.03","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.99","spread":null},{"groupId":"OG001","value":"1.07","spread":null},{"groupId":"OG002","value":"1.23","spread":null},{"groupId":"OG003","value":"1.20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":null},{"groupId":"OG001","value":"0.52","spread":null},{"groupId":"OG002","value":"1.14","spread":null},{"groupId":"OG003","value":"1.01","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.40","spread":null},{"groupId":"OG001","value":"0.86","spread":null},{"groupId":"OG002","value":"1.12","spread":null},{"groupId":"OG003","value":"1.06","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life as Assessed by the FACT-P : Social Well-being","description":"The FACT-P is a multidimensional, self-report quality of life (QoL) instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being, which is further supplemented by 12 site specific items to assess for prostate related symptoms. Each question is rated on a scale from 0 to 4, and then combined to produce sub-scale scores for each domain, as well as a global QoL score.\n\nSocial well-being consist of 7 items and scored on a scale of 0-4 (0=Not at all; 1=A little bit; 2=Somewhat; 3=Quite a bit; 4=Very much). Total score for the social well-being sub scale ranges from 0 to 28. Higher scores represent better QoL.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.18","spread":null},{"groupId":"OG001","value":"-0.06","spread":null},{"groupId":"OG002","value":"-0.36","spread":null},{"groupId":"OG003","value":"-0.30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":null},{"groupId":"OG001","value":"-0.30","spread":null},{"groupId":"OG002","value":"-0.46","spread":null},{"groupId":"OG003","value":"-0.43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.33","spread":null},{"groupId":"OG001","value":"-0.52","spread":null},{"groupId":"OG002","value":"-0.41","spread":null},{"groupId":"OG003","value":"-0.43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":null},{"groupId":"OG001","value":"-0.95","spread":null},{"groupId":"OG002","value":"-1.10","spread":null},{"groupId":"OG003","value":"-1.07","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.36","spread":null},{"groupId":"OG001","value":"-1.00","spread":null},{"groupId":"OG002","value":"-1.15","spread":null},{"groupId":"OG003","value":"-1.12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.20","spread":null},{"groupId":"OG001","value":"-1.09","spread":null},{"groupId":"OG002","value":"-0.83","spread":null},{"groupId":"OG003","value":"-0.88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.16","spread":null},{"groupId":"OG001","value":"-1.34","spread":null},{"groupId":"OG002","value":"-0.85","spread":null},{"groupId":"OG003","value":"-0.95","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":null},{"groupId":"OG001","value":"-1.35","spread":null},{"groupId":"OG002","value":"-0.72","spread":null},{"groupId":"OG003","value":"-0.85","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.28","spread":null},{"groupId":"OG001","value":"-0.68","spread":null},{"groupId":"OG002","value":"-0.55","spread":null},{"groupId":"OG003","value":"-0.58","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life as Assessed by the FACT-P : Functional Well-being","description":"The FACT-P is a multidimensional, self-report quality of life (QoL) instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being, which is further supplemented by 12 site specific items to assess for prostate related symptoms. Each question is rated on a scale from 0 to 4, and then combined to produce sub-scale scores for each domain, as well as a global QoL score.\n\nFunctional well-being consist of 7 items and scored on a scale of 0-4 (0=Not at all; 1=A little bit; 2=Somewhat; 3=Quite a bit; 4=Very much). Total score for the functional well-being sub scale ranges from 0 to 28. Higher scores represent better QoL.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.96","spread":null},{"groupId":"OG001","value":"-0.88","spread":null},{"groupId":"OG002","value":"-0.29","spread":null},{"groupId":"OG003","value":"-0.42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.41","spread":null},{"groupId":"OG001","value":"-0.78","spread":null},{"groupId":"OG002","value":"-1.24","spread":null},{"groupId":"OG003","value":"-1.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.18","spread":null},{"groupId":"OG001","value":"-1.08","spread":null},{"groupId":"OG002","value":"-0.73","spread":null},{"groupId":"OG003","value":"-0.80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.14","spread":null},{"groupId":"OG001","value":"-1.07","spread":null},{"groupId":"OG002","value":"-1.23","spread":null},{"groupId":"OG003","value":"-1.20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.35","spread":null},{"groupId":"OG001","value":"-0.89","spread":null},{"groupId":"OG002","value":"-1.42","spread":null},{"groupId":"OG003","value":"-1.31","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.25","spread":null},{"groupId":"OG001","value":"-0.80","spread":null},{"groupId":"OG002","value":"-1.24","spread":null},{"groupId":"OG003","value":"-1.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.92","spread":null},{"groupId":"OG001","value":"-1.49","spread":null},{"groupId":"OG002","value":"-0.73","spread":null},{"groupId":"OG003","value":"-0.89","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.49","spread":null},{"groupId":"OG001","value":"-2.22","spread":null},{"groupId":"OG002","value":"-0.96","spread":null},{"groupId":"OG003","value":"-1.22","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.02","spread":null},{"groupId":"OG001","value":"-1.95","spread":null},{"groupId":"OG002","value":"-0.84","spread":null},{"groupId":"OG003","value":"-1.07","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life as Assessed by the FACT-P : Additional Concerns","description":"The FACT-P is a multidimensional, self-report quality of life (QoL) instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being, which is further supplemented by 12 site specific items to assess for prostate related symptoms. Each question is rated on a scale from 0 to 4, and then combined to produce sub-scale scores for each domain, as well as a global QoL score.\n\nAdditional concerns consist of 12 items and scored on a scale of 0-4 (0=Not at all; 1=A little bit; 2=Somewhat; 3=Quite a bit; 4=Very much). Total score for the additional concerns ranges from 0 to 48. Higher scores represent better QoL.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.14","spread":null},{"groupId":"OG001","value":"-0.92","spread":null},{"groupId":"OG002","value":"-0.51","spread":null},{"groupId":"OG003","value":"-0.60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.89","spread":null},{"groupId":"OG001","value":"-1.34","spread":null},{"groupId":"OG002","value":"-1.03","spread":null},{"groupId":"OG003","value":"-1.10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.29","spread":null},{"groupId":"OG001","value":"-1.03","spread":null},{"groupId":"OG002","value":"-0.63","spread":null},{"groupId":"OG003","value":"-0.72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.97","spread":null},{"groupId":"OG001","value":"-1.64","spread":null},{"groupId":"OG002","value":"-0.90","spread":null},{"groupId":"OG003","value":"-1.06","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.86","spread":null},{"groupId":"OG001","value":"-0.80","spread":null},{"groupId":"OG002","value":"-0.70","spread":null},{"groupId":"OG003","value":"-0.72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.80","spread":null},{"groupId":"OG001","value":"-0.56","spread":null},{"groupId":"OG002","value":"-0.58","spread":null},{"groupId":"OG003","value":"-0.57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.75","spread":null},{"groupId":"OG001","value":"-1.20","spread":null},{"groupId":"OG002","value":"-0.75","spread":null},{"groupId":"OG003","value":"-0.84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.91","spread":null},{"groupId":"OG001","value":"-0.96","spread":null},{"groupId":"OG002","value":"-0.86","spread":null},{"groupId":"OG003","value":"-0.88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.81","spread":null},{"groupId":"OG001","value":"-0.67","spread":null},{"groupId":"OG002","value":"-0.27","spread":null},{"groupId":"OG003","value":"-0.35","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Quality of Life as Assessed by the FACT-P: Total FACT-P Score","description":"The FACT-P is a multidimensional, self-report quality of life (QoL) instrument specifically designed for use with prostate cancer patients. It consists of 27 core items which assess patient function in four domains: Physical, Social/Family, Emotional, and Functional well-being, which is further supplemented by 12 site specific items to assess for prostate related symptoms. Each question is rated on a scale from 0 to 4, and then combined to produce sub-scale scores for each domain, as well as a global QoL score. Total FACT-P scores ranges from 0 to 156. Higher scores represent better QoL.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.86","spread":null},{"groupId":"OG001","value":"-1.89","spread":null},{"groupId":"OG002","value":"-1.23","spread":null},{"groupId":"OG003","value":"-1.37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.03","spread":null},{"groupId":"OG001","value":"-2.64","spread":null},{"groupId":"OG002","value":"-2.38","spread":null},{"groupId":"OG003","value":"-2.43","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.75","spread":null},{"groupId":"OG001","value":"-3.12","spread":null},{"groupId":"OG002","value":"-1.69","spread":null},{"groupId":"OG003","value":"-1.99","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.61","spread":null},{"groupId":"OG001","value":"-3.49","spread":null},{"groupId":"OG002","value":"-2.84","spread":null},{"groupId":"OG003","value":"-2.98","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.89","spread":null},{"groupId":"OG001","value":"-4.56","spread":null},{"groupId":"OG002","value":"-3.16","spread":null},{"groupId":"OG003","value":"-3.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.18","spread":null},{"groupId":"OG001","value":"-3.27","spread":null},{"groupId":"OG002","value":"-2.48","spread":null},{"groupId":"OG003","value":"-2.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.95","spread":null},{"groupId":"OG001","value":"-3.97","spread":null},{"groupId":"OG002","value":"-1.60","spread":null},{"groupId":"OG003","value":"-2.09","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.74","spread":null},{"groupId":"OG001","value":"-5.62","spread":null},{"groupId":"OG002","value":"-1.85","spread":null},{"groupId":"OG003","value":"-2.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.36","spread":null},{"groupId":"OG001","value":"-4.28","spread":null},{"groupId":"OG002","value":"-1.65","spread":null},{"groupId":"OG003","value":"-2.20","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sexual Function as Assessed by the Sexual Function Index (SFI): Sexual Drive","description":"The SFI is a multidimensional, self-report instrument specifically designed to evaluate sexual function and satisfaction of men on treatment or with conditions that may affect sexual function. It consists of 11 questions which assess patient function in four domains: Sexual drive, Erection, Ejaculation, and Problem assessment, and a question in regards to overall assessment of sexual function.\n\nSexual drive domain consist of 2 questions and are scored on a scale of 0-4 (0=minimum, 4=maximum). Total score for the sexual drive domain ranges from 0 to 8. A higher scores represent better sexual function.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.57","spread":null},{"groupId":"OG001","value":"-1.57","spread":null},{"groupId":"OG002","value":"-1.27","spread":null},{"groupId":"OG003","value":"-1.33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.71","spread":null},{"groupId":"OG001","value":"-1.39","spread":null},{"groupId":"OG002","value":"-1.67","spread":null},{"groupId":"OG003","value":"-1.61","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.72","spread":null},{"groupId":"OG001","value":"-1.51","spread":null},{"groupId":"OG002","value":"-1.62","spread":null},{"groupId":"OG003","value":"-1.60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.59","spread":null},{"groupId":"OG001","value":"-1.52","spread":null},{"groupId":"OG002","value":"-1.65","spread":null},{"groupId":"OG003","value":"-1.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.44","spread":null},{"groupId":"OG001","value":"-1.55","spread":null},{"groupId":"OG002","value":"-1.72","spread":null},{"groupId":"OG003","value":"-1.69","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.30","spread":null},{"groupId":"OG001","value":"-1.65","spread":null},{"groupId":"OG002","value":"-1.72","spread":null},{"groupId":"OG003","value":"-1.71","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sexual Function as Assessed by the SFI: Erection","description":"The SFI is a multidimensional, self-report instrument specifically designed to evaluate sexual function and satisfaction of men on treatment or with conditions that may affect sexual function. It consists of 11 questions which assess patient function in four domains: Sexual drive, Erection, Ejaculation, and Problem assessment, and a question in regards to overall assessment of sexual function.\n\nErection domain consist of 3 questions and are scored on a scale of 0-4 (0=minimum, 4=maximum). Total score for the erection domain ranges from 0 to 12. A higher scores represent better sexual function.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.32","spread":null},{"groupId":"OG001","value":"-0.91","spread":null},{"groupId":"OG002","value":"-1.21","spread":null},{"groupId":"OG003","value":"-1.14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.43","spread":null},{"groupId":"OG001","value":"-1.06","spread":null},{"groupId":"OG002","value":"-1.34","spread":null},{"groupId":"OG003","value":"-1.28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.52","spread":null},{"groupId":"OG001","value":"-1.07","spread":null},{"groupId":"OG002","value":"-1.46","spread":null},{"groupId":"OG003","value":"-1.38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.15","spread":null},{"groupId":"OG001","value":"-1.34","spread":null},{"groupId":"OG002","value":"-1.28","spread":null},{"groupId":"OG003","value":"-1.30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.97","spread":null},{"groupId":"OG001","value":"-1.36","spread":null},{"groupId":"OG002","value":"-1.33","spread":null},{"groupId":"OG003","value":"-1.34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.90","spread":null},{"groupId":"OG001","value":"-1.43","spread":null},{"groupId":"OG002","value":"-1.26","spread":null},{"groupId":"OG003","value":"-1.29","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sexual Function as Assessed by the SFI: Ejaculation","description":"The SFI is a multidimensional, self-report instrument specifically designed to evaluate sexual function and satisfaction of men on treatment or with conditions that may affect sexual function. It consists of 11 questions which assess patient function in four domains: Sexual drive, Erection, Ejaculation, and Problem assessment, and a question in regards to overall assessment of sexual function.\n\nEjaculation domain consist of 2 questions and are scored on a scale of 0-4 (0=minimum, 4=maximum). Total score for the ejaculation domain ranges from 0 to 8. A higher scores represent better sexual function.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.04","spread":null},{"groupId":"OG001","value":"-0.90","spread":null},{"groupId":"OG002","value":"-0.87","spread":null},{"groupId":"OG003","value":"-0.88","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.23","spread":null},{"groupId":"OG001","value":"-0.80","spread":null},{"groupId":"OG002","value":"-1.08","spread":null},{"groupId":"OG003","value":"-1.02","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.24","spread":null},{"groupId":"OG001","value":"-1.06","spread":null},{"groupId":"OG002","value":"-0.94","spread":null},{"groupId":"OG003","value":"-0.97","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.94","spread":null},{"groupId":"OG001","value":"-1.24","spread":null},{"groupId":"OG002","value":"-0.93","spread":null},{"groupId":"OG003","value":"-1.00","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.89","spread":null},{"groupId":"OG001","value":"-1.07","spread":null},{"groupId":"OG002","value":"-1.12","spread":null},{"groupId":"OG003","value":"-1.11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.79","spread":null},{"groupId":"OG001","value":"-1.17","spread":null},{"groupId":"OG002","value":"-0.97","spread":null},{"groupId":"OG003","value":"-1.01","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sexual Function as Assessed by the SFI: Problem Assessment","description":"The SFI is a multidimensional, self-report instrument specifically designed to evaluate sexual function and satisfaction of men on treatment or with conditions that may affect sexual function. It consists of 11 questions which assess patient function in four domains: Sexual drive, Erection, Ejaculation, and Problem assessment, and a question in regards to overall assessment of sexual function.\n\nProblem assessment domain consist of 2 questions and are scored on a scale of 0-4 (0=minimum, 4=maximum). Total score for the problem assessment domain ranges from 0 to 8. A higher scores represent better sexual function.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.26","spread":null},{"groupId":"OG001","value":"-0.58","spread":null},{"groupId":"OG002","value":"-0.36","spread":null},{"groupId":"OG003","value":"-0.40","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.90","spread":null},{"groupId":"OG001","value":"-0.88","spread":null},{"groupId":"OG002","value":"-0.57","spread":null},{"groupId":"OG003","value":"-0.63","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.56","spread":null},{"groupId":"OG001","value":"-0.71","spread":null},{"groupId":"OG002","value":"-0.64","spread":null},{"groupId":"OG003","value":"-0.66","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.09","spread":null},{"groupId":"OG001","value":"-0.53","spread":null},{"groupId":"OG002","value":"-0.98","spread":null},{"groupId":"OG003","value":"-0.89","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.15","spread":null},{"groupId":"OG001","value":"-1.63","spread":null},{"groupId":"OG002","value":"-1.07","spread":null},{"groupId":"OG003","value":"-1.19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.31","spread":null},{"groupId":"OG001","value":"-1.68","spread":null},{"groupId":"OG002","value":"-0.89","spread":null},{"groupId":"OG003","value":"-1.05","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sexual Function as Assessed by the SFI: Overall Satisfaction With Sex Life","description":"The SFI is a multidimensional, self-report instrument specifically designed to evaluate sexual function and satisfaction of men on treatment or with conditions that may affect sexual function. It consists of 11 questions which assess patient function in four domains: Sexual drive, Erection, Ejaculation, and Problem assessment, and a question in regards to overall assessment of sexual function.\n\nOverall satisfaction domain consist of single question and is scored on a scale of 0-4 (0=minimum, 4=maximum). A higher score represent better sexual function.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.32","spread":null},{"groupId":"OG001","value":"-0.18","spread":null},{"groupId":"OG002","value":"-0.27","spread":null},{"groupId":"OG003","value":"-0.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.28","spread":null},{"groupId":"OG001","value":"-0.37","spread":null},{"groupId":"OG002","value":"-0.40","spread":null},{"groupId":"OG003","value":"-0.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.33","spread":null},{"groupId":"OG001","value":"-0.34","spread":null},{"groupId":"OG002","value":"-0.41","spread":null},{"groupId":"OG003","value":"-0.39","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.15","spread":null},{"groupId":"OG001","value":"-0.47","spread":null},{"groupId":"OG002","value":"-0.41","spread":null},{"groupId":"OG003","value":"-0.42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":null},{"groupId":"OG001","value":"-0.57","spread":null},{"groupId":"OG002","value":"-0.42","spread":null},{"groupId":"OG003","value":"-0.45","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.12","spread":null},{"groupId":"OG001","value":"-0.70","spread":null},{"groupId":"OG002","value":"-0.37","spread":null},{"groupId":"OG003","value":"-0.44","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Sexual Function as Assessed by the SFI: Total SFI Score","description":"The SFI is a multidimensional, self-report instrument specifically designed to evaluate sexual function and satisfaction of men on treatment or with conditions that may affect sexual function. It consists of 11 questions which assess patient function in four domains: Sexual drive, Erection, Ejaculation, and Problem assessment, and a question in regards to overall assessment of sexual function. Total SFI score ranges from 0 to 44. A higher scores represent better sexual function.","paramType":"MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.07","spread":null},{"groupId":"OG001","value":"-3.93","spread":null},{"groupId":"OG002","value":"-3.69","spread":null},{"groupId":"OG003","value":"-3.74","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.20","spread":null},{"groupId":"OG001","value":"-4.28","spread":null},{"groupId":"OG002","value":"-4.57","spread":null},{"groupId":"OG003","value":"-4.51","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.97","spread":null},{"groupId":"OG001","value":"-4.35","spread":null},{"groupId":"OG002","value":"-4.62","spread":null},{"groupId":"OG003","value":"-4.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.56","spread":null},{"groupId":"OG001","value":"-4.62","spread":null},{"groupId":"OG002","value":"-4.74","spread":null},{"groupId":"OG003","value":"-4.71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.37","spread":null},{"groupId":"OG001","value":"-5.59","spread":null},{"groupId":"OG002","value":"-5.15","spread":null},{"groupId":"OG003","value":"-5.24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.27","spread":null},{"groupId":"OG001","value":"-5.93","spread":null},{"groupId":"OG002","value":"-4.68","spread":null},{"groupId":"OG003","value":"-4.94","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Subjects With a Serum PSA Level ≤4.0 ng/mL","description":"Percentage of Subjects With a Serum PSA Level ≤4.0 ng/mL was measured during the study period.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"97.6","spread":null},{"groupId":"OG002","value":"98.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Return to Testosterone >0.5 ng/mL Level in the DI Treatment Group","description":"The time to testosterone \\>0.5 ng/mL level in the DI group was counted from the start of Phase B at Day 196 (i.e. 28 days after last injection of degarelix)","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"112.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Return to Normal Range (≥1.5 ng/mL) or Baseline Testosterone Level","description":"The time to return to normal range (≥1.5 ng/mL) or Baseline testosterone level in the DI group was counted from the start of Phase B at Day 196 (i.e. 28 days after last injection of degarelix).","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"168","spread":null}]}]}]},{"type":"SECONDARY","title":"Absolute Change From Baseline in Serum Testosterone Levels","description":"Absolute Change From Baseline in Serum Testosterone Levels was measured.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA"},{"groupId":"OG001","value":"-2.97","spread":"NA"},{"groupId":"OG002","value":"NA","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.64","spread":"1.4"},{"groupId":"OG001","value":"-3.77","spread":"1.43"},{"groupId":"OG002","value":"-3.7","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.67","spread":"1.4"},{"groupId":"OG001","value":"-3.77","spread":"1.44"},{"groupId":"OG002","value":"-3.77","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.68","spread":"1.4"},{"groupId":"OG001","value":"-3.78","spread":"1.43"},{"groupId":"OG002","value":"-3.77","spread":"1.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.67","spread":"1.41"},{"groupId":"OG001","value":"-3.78","spread":"1.44"},{"groupId":"OG002","value":"-3.74","spread":"1.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.67","spread":"1.41"},{"groupId":"OG001","value":"-3.78","spread":"1.44"},{"groupId":"OG002","value":"-3.78","spread":"1.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.66","spread":"1.41"},{"groupId":"OG001","value":"-3.77","spread":"1.44"},{"groupId":"OG002","value":"-3.77","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.66","spread":"1.42"},{"groupId":"OG001","value":"-3.78","spread":"1.43"},{"groupId":"OG002","value":"-3.78","spread":"1.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.63","spread":"1.44"},{"groupId":"OG001","value":"-3.76","spread":"1.44"},{"groupId":"OG002","value":"-3.78","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.41","spread":"1.6"},{"groupId":"OG001","value":"-3.76","spread":"1.44"},{"groupId":"OG002","value":"-3.78","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.0","spread":"1.76"},{"groupId":"OG001","value":"-3.75","spread":"1.44"},{"groupId":"OG002","value":"-3.77","spread":"1.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.57","spread":"1.78"},{"groupId":"OG001","value":"-3.74","spread":"1.43"},{"groupId":"OG002","value":"-3.78","spread":"1.55"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.18","spread":"1.8"},{"groupId":"OG001","value":"-3.72","spread":"1.43"},{"groupId":"OG002","value":"-3.78","spread":"1.56"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.1","spread":"1.81"},{"groupId":"OG001","value":"-3.73","spread":"1.42"},{"groupId":"OG002","value":"-3.77","spread":"1.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.77","spread":"2.27"},{"groupId":"OG001","value":"-3.71","spread":"1.42"},{"groupId":"OG002","value":"-3.78","spread":"1.56"}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Serum Testosterone Levels","description":"Percent change from Baseline in serum testosterone levels was measured.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA"},{"groupId":"OG001","value":"-95.8","spread":"NA"},{"groupId":"OG002","value":"NA","spread":"NA"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-96.4","spread":"5.26"},{"groupId":"OG001","value":"-97.4","spread":"2.31"},{"groupId":"OG002","value":"-95.5","spread":"4.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-97.3","spread":"2.46"},{"groupId":"OG001","value":"-97.5","spread":"1.9"},{"groupId":"OG002","value":"-97.7","spread":"1.44"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-97.5","spread":"2.06"},{"groupId":"OG001","value":"-97.8","spread":"1.41"},{"groupId":"OG002","value":"-97.5","spread":"1.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-97.2","spread":"4.26"},{"groupId":"OG001","value":"-97.7","spread":"1.58"},{"groupId":"OG002","value":"-96.2","spread":"14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-97.3","spread":"4.42"},{"groupId":"OG001","value":"-97.6","spread":"2.49"},{"groupId":"OG002","value":"-97.8","spread":"1.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-96.8","spread":"7.01"},{"groupId":"OG001","value":"-97.6","spread":"2.03"},{"groupId":"OG002","value":"-97.9","spread":"1.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-96.9","spread":"6.34"},{"groupId":"OG001","value":"-97.5","spread":"2.54"},{"groupId":"OG002","value":"-97.7","spread":"1.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-95.6","spread":"9.69"},{"groupId":"OG001","value":"-97.1","spread":"3.09"},{"groupId":"OG002","value":"-97.8","spread":"1.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-88.7","spread":"24.7"},{"groupId":"OG001","value":"-97","spread":"3.14"},{"groupId":"OG002","value":"-97.7","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-77","spread":"34.8"},{"groupId":"OG001","value":"-97","spread":"3.74"},{"groupId":"OG002","value":"-97.5","spread":"3.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-65.4","spread":"37.7"},{"groupId":"OG001","value":"-96.7","spread":"3.43"},{"groupId":"OG002","value":"-97.9","spread":"1.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-54.7","spread":"41.5"},{"groupId":"OG001","value":"-96","spread":"5.56"},{"groupId":"OG002","value":"-97.8","spread":"1.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-51.9","spread":"43.1"},{"groupId":"OG001","value":"-96.5","spread":"3.7"},{"groupId":"OG002","value":"-97.4","spread":"4.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-44","spread":"66.1"},{"groupId":"OG001","value":"-95.8","spread":"4.8"},{"groupId":"OG002","value":"-97.7","spread":"1.56"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":26,"n":175},"commonTop":["Hot flush","Injection site pain","Fatigue","Injection site erythema","Arthralgia"]}}}